Verifying GRAS Status for Food Ingredients: FDA Database, Notifications, and Self-Affirmation

An ingredient supplier sends a spec sheet that says “GRAS” in bold across the top. That label alone is not verification—GRAS status comes in three flavors (FDA-affirmed, GRAS Notice with no-questions response, and self-affirmed), and only the first two carry an FDA paper trail. A formulator who treats “GRAS” as a single thing risks shipping a product with an ingredient that has no public safety review behind it. This walks the verification workflow: how to check the GRAS Notice Inventory, how to read the response letters, what to do when an ingredient is not in the database, and the usage-level conditions that make GRAS status conditional.

What GRAS Actually Means

“Generally Recognized as Safe” is a designation under the Federal Food, Drug, and Cosmetic Act for substances added to food that have either (a) a long history of common use in food before 1958, or (b) scientific evidence sufficient to demonstrate safety under intended conditions of use. The legal effect is that GRAS substances are exempt from the food additive premarket approval process. The practical effect is that manufacturers can use GRAS ingredients without filing a food additive petition.

Three pathways produce GRAS status:

1. FDA-affirmed GRAS: historical pathway from the 1970s and 1980s, codified at 21 CFR Part 184 (direct food substances) and Part 186 (indirect food substances). FDA reviewed safety data and affirmed the substance as GRAS. This program is no longer active for new affirmations.
2. GRAS Notice with FDA no-questions response: the active program since 1997. A notifier submits safety data and a GRAS conclusion to FDA. FDA reviews and issues one of three responses: “no questions” (FDA does not contest the GRAS determination), “insufficient basis” (FDA disagrees), or the notice is withdrawn by the notifier.
3. Self-affirmed GRAS: the manufacturer or supplier convenes an independent expert panel that reviews safety data and concludes the substance is GRAS. No FDA involvement. The conclusion is documented internally and may be shared with customers, but it carries no public safety record.

The verification workflow differs by pathway. FDA-affirmed and GRAS Notice substances are checkable in public databases. Self-affirmed GRAS requires reviewing the supplier’s expert panel report, which is rarely shared in full and may not exist as a complete document.

Step 1: Search the GRAS Notice Inventory

The GRAS Notice Inventory is FDA’s public database of substances that have gone through the GRAS Notice program since 1997. The inventory is searchable by substance name, GRAS Notice number (GRN), notifier, intended use, or response date. Typing “stevia” into the search returns all GRNs related to steviol glycosides; clicking a row reveals the notifier, the intended food categories, the use levels, and the FDA response letter.

The inventory updates approximately monthly. New GRNs appear after FDA accepts the filing for review; the response letter is added when the agency completes its evaluation. A pending GRN means FDA is still reviewing—the substance is not yet GRAS through the notice pathway, although the notifier may be using it under self-affirmation.

Key fields to capture for each GRN:

• GRN number (e.g., GRN 000999)
• Substance identity (specific chemical or biological identity, not just the trade name)
• Intended use (food categories where the substance is GRAS for use)
• Maximum use level (typically expressed as percent or ppm in the food category)
• FDA response (no questions / insufficient basis / withdrawn)
• Date of response (recency matters; safety standards evolve)

Step 2: Verify Your Use Matches the Notice

GRAS status under the notice program is conditional on the intended use described in the notice. A substance with a no-questions response for use in baked goods at 1% may not be GRAS for use in beverages at 5%. Verifying that your application falls within the conditions of use is as important as verifying the substance appears in the inventory.

If your intended use exceeds the notice’s conditions, you have three options: (a) find a different GRN that covers your use, (b) commission your own GRAS notice or self-affirmation that includes your use conditions, or (c) submit a food additive petition. Option (a) is the most common; substances popular in food formulation typically have multiple GRNs covering different use categories.

Step 3: Cross-Check the Affirmed GRAS List

Substances FDA affirmed as GRAS in the older program are codified in 21 CFR Parts 182, 184, and 186. Parts 184 and 186 list direct and indirect food substances respectively; Part 182 contains substances historically considered GRAS. Affirmed GRAS substances are checkable on the eCFR website; search for the substance name within Part 184 or browse the list.

Affirmed GRAS listings include the substance, the conditions of use, and (in some cases) maximum use levels. Conditions are often less granular than GRAS Notice conditions because the affirmation program ran before the notice-program structure existed. If a substance appears in Part 184, it is GRAS for use as specified in the regulation, with no separate FDA letter required.

Step 4: Handle Self-Affirmed GRAS Carefully

If an ingredient is not in the GRAS Notice Inventory and not in 21 CFR Parts 182, 184, or 186, the supplier may be relying on self-affirmation. Self-affirmation is legally valid—FDA does not require notification to use a substance under self-affirmed GRAS—but it requires due diligence on the part of the formulator using it.

The minimum verification on a self-affirmed GRAS ingredient:

1. Request the supplier’s GRAS dossier or a summary of the expert panel’s safety conclusion
2. Confirm the panel was independent (not employed by the supplier) and consisted of qualified experts (typically toxicologists, food scientists, or regulatory specialists)
3. Confirm the conditions of use in the panel’s conclusion match your intended use (food category, maximum level, target population)
4. Document the verification in your formulation file—FDA inspectors may ask how you concluded the ingredient was safe

Self-affirmed GRAS without supplier documentation is not verification. “The supplier said it’s GRAS” is not a defense in an FDA enforcement action. If the supplier cannot or will not provide the dossier, the formulator should treat the ingredient as not-yet-verified and either escalate to a different supplier or request that the supplier submit a GRAS notice.

Step 5: Document the Verification Trail

For every ingredient in the formula, the formulation file should contain:

• The supplier’s spec sheet with the substance identity, purity, and any allergen disclosures
• The GRAS pathway (FDA-affirmed, GRAS Notice GRN number, or self-affirmed with dossier reference)
• The conditions of use that authorize the substance for this product (food category, maximum level)
• The date the verification was last reviewed (substances can be re-evaluated as new safety data emerges)

This file becomes the regulatory evidence package if FDA inspects the facility, if a co-manufacturer requests proof of ingredient compliance, or if a retailer audits the product before listing. Building it during formulation is much easier than reconstructing it after the fact.

What to Do When an Ingredient Has No GRAS Pathway

Some ingredients are not GRAS at all—they are food additives requiring premarket approval. Color additives, certain preservatives, and many novel ingredients fall in this category. The FDA’s GRAS overview page distinguishes GRAS from food additive status. If verification reveals an ingredient has no GRAS basis and no food additive approval, it cannot legally be added to food in the US.

Encountering this situation late in formulation usually means the supplier’s representations were inaccurate, the ingredient is intended for a non-food use, or the regulatory landscape changed since the supplier last reviewed it. The fix is to either find a substitute ingredient with verified GRAS status or to pursue food additive approval—a multi-year process that is rarely the right path for a small or mid-size formulator.

Compliance for the rest of the label depends on the ingredient list being defensible. The ingredient declaration order rules under 21 CFR 101.4 assume every listed ingredient has a legal basis for being in the food; an ingredient without GRAS or food-additive status invalidates the entire ingredient statement.